J.W. Cole Advisors, Inc. Astrazeneca PLC Transaction History

J.W. Cole Advisors, Inc.

$3.14 Billion
Q1 2025

A detailed history of J.W. Cole Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 20,318 shares of AZN stock, worth $1.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

20,318

Previous 4,542 347.34%

Holding current value

$1.5 Million

Previous $297,000 402.69%

% of portfolio

0.05%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	BUY	$65.37 - $77.96 $1.03 Million - $1.23 Million	15,776 Added 347.34%	20,318 $1.49 Million
Q4 2024 Jan 30, 2025	SELL	$63.2 - $79.58 $60,924 - $76,715	-964 Reduced 17.51%	4,542 $297,000
Q3 2024 Oct 24, 2024	SELL	$76.67 - $87.62 $3,680 - $4,205	-48 Reduced 0.86%	5,506 $429,000
Q2 2024 Aug 08, 2024	SELL	$66.81 - $80.83 $41,288 - $49,952	-618 Reduced 10.01%	5,554 $433,000
Q1 2024 Apr 30, 2024	BUY	$61.03 - $69.57 $16,539 - $18,853	271 Added 4.59%	6,172 $418,000
Q4 2023 Jan 31, 2024	SELL	$61.89 - $69.28 $618 - $692	-10 Reduced 0.17%	5,901 $397,000
Q3 2023 Oct 24, 2023	BUY	$64.85 - $71.7 $59,726 - $66,035	921 Added 18.46%	5,911 $400,000
Q2 2023 Jul 27, 2023	SELL	$69.91 - $75.81 $7,690 - $8,339	-110 Reduced 2.16%	4,990 $357,000
Q1 2023 May 03, 2023	SELL	$63.15 - $71.6 $286,637 - $324,992	-4,539 Reduced 47.09%	5,100 $353,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $252,401 - $327,968	4,656 Added 93.44%	9,639 $653,000
Q3 2022 Oct 31, 2022	BUY	$53.02 - $135.75 $55,034 - $140,908	1,038 Added 26.31%	4,983 $273,000
Q2 2022 Jul 27, 2022	SELL	$59.26 - $71.14 $26,015 - $31,230	-439 Reduced 10.01%	3,945 $261,000
Q1 2022 Jun 10, 2022	SELL	$55.72 - $67.12 $9.76 Million - $11.8 Million	-175,228 Reduced 97.56%	4,384 $291,000
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $9.76 Million - $11.8 Million	175,215 Added 3984.88%	179,612 $116,000
Q4 2021 Jan 25, 2022	BUY	$54.02 - $63.83 $23,120 - $27,319	428 Added 10.78%	4,397 $256,000
Q3 2021 Oct 26, 2021	BUY	$55.56 - $60.79 $7,333 - $8,024	132 Added 3.44%	3,969 $238,000
Q2 2021 Aug 06, 2021	BUY	$48.42 - $60.18 $185,787 - $230,910	3,837 New	3,837 $230,000
Q1 2021 Apr 28, 2021	SELL	$47.16 - $54.44 $229,810 - $265,286	-4,873 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $995,048 - $1.19 Million	-20,508 Reduced 80.8%	4,873 $244,000
Q3 2020 Nov 05, 2020	BUY	$53.07 - $61.1 $1.35 Million - $1.55 Million	25,381 New	25,381 $1.39 Million
Q1 2020 May 07, 2020	SELL	$37.79 - $51.33 $186,607 - $253,467	-4,938 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$42.46 - $50.46 $209,667 - $249,171	4,938 New	4,938 $246,000

Others Institutions Holding AZN

# of Institutions

1,425

Shares Held

505M

Call Options Held

9.82M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $229B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Account

J.W. Cole Advisors, Inc. Astrazeneca PLC Transaction History